Gastro-esophageal reflux disease (GERD) among medical students during COVID-19 pandemic: A cross sectional study

Mohammad Zaidan; Suzan Al-Hawash; Niazy Abdul-Fattah Abu Farsakh; Khalid Khairallah

doi:10.58877/japaj.v1i1.6

Authors

Mohammad Zaidan Jordan university of Science and technology
Suzan Al-Hawash Jordan University of Science and Technology
Prof. Niazy Abu Farsakh Jordan university of Science and technology
Ph.D. Khalid Khairallah Jordan university of Science and technology

DOI:

https://doi.org/10.58877/japaj.v1i1.6

Keywords:

GERD, COVID-19, Internal medicine, medical students, regurgitations

Abstract

Abstract:

Importance: Gastroesophageal reflux disease (GERD) is a common digestive disorder in which acid-containing contents in your stomach persistently leak back up into the esophagus, especially in stressful lifestyle such as medical students.

Objective: The aim of this study is to estimate the prevalence of GERD in Medical students in Jordan, assess factors which affect the occurrence of GERD in the study population, access the stressors of medical students during the pandemic, assess, if any, effect is present related to COVID-19 pandemic, and to look for possible preventive measures for GERD.

Design: cross-sectional study including a questionnaire of 6 questions of the duration of seven days prepared on google forms and electronically. Data was collected in the period between 31st January 2021 and 18th April 2021.

Setting: Medical Faculties and hospitals in Jordan.

Participants: population-based sample; medical students studying in Jordan.

Main outcomes and Measures: Medical students' lifestyles are stressful, and a lot of risk factors attributed to GERD are common among medical students. COVID-19 infection is known to cause GI symptoms and as an infection, it could be a stressor especially during the pandemic. Statistical methods included descriptive analysis, Cramer's V statistics, and the Chi-square test as measures of effect sizes. Our findings were not significant enough to confirm that COVID-19 infection causes GERD. However, alternation in GERD symptoms was found to be significant.

Results: Out of 1009 subjects, 43.4% were males, and 56.6% were females. The most common symptoms were heartburn and regurgitations and were found in 421 (41.7%) and 325 (32.2%) students, respectively. 199 (19.7%) of students were affected by COVID-19 but it was not statistically significant (P >0.05). However, alteration in the feeling of GERD symptoms in those who were infected with COVID-19 was found to be statistically significant (P < 0.05).

Conclusion and relevance: Our findings suggest that the most frequent symptoms of GERD reported by medical students are heartburn and regurgitation. In addition to that, the students who were infected with COVID-19 were in the high-risk group. Therefore, more efforts and studies are needed to look for the pathophysiology of COVID-19 infection's effect on the GERD symptoms.

Keywords:

GERD, Regurgitation, COVID-19, Pandemic.

References

References:

Mousa, H., & Hassan, M. (2017). Gastroesophageal Reflux Disease. Pediatric Clinics of North America, 64(3), 487–505. https://doi.org/10.1016/j.pcl.2017.01.003

El-Serag HB, Sweet S, Winchester CC, Dent J. Update on the epidemiology of gastroesophageal reflux disease: a systematic review. Gut. 2014 Jun;63(6):871-80. Doi: 10.1136/gutjnl-2012-304269. Epub 2013 Jul 13. PMID: 23853213; PMCID: PMC4046948.

Clarrett DM, Hachem C. Gastroesophageal Reflux Disease (GERD). Mo Med. 2018 May-Jun;115(3):214-218. PMID: 30228725; PMCID: PMC6140167.

Argyrou, A., Legaki, E., Koutserimpas, C., Gazouli, M., Papaconstantinou, I., Gkiokas, G., &Karamanolis, G. (2018). Risk factors for gastroesophageal reflux disease and analysis of genetic contributors. World Journal of Clinical Cases, 6(8), 176 182.https://doi.org/10.12998/wjcc.v6.i8.176

Nouraie M, Razjouyan H, Assady M, Malekzadeh R, Nasseri-Moghaddam S. Epidemiology of gastroesophageal reflux symptoms in Tehran, Iran: a population-based telephone survey. Arch Iran Med. 2007; 10:289-294.

Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013; 108:915-22.

Syam, Ari &Hapsari, Puspita&Makmun, Dadang. (2016). The Prevalence and Risk Factors of GERD among Indonesian Medical Doctors. Makara Journal of Health Research. 20. 10.7454/msk. v20i2.5740.

Jung H-K. Epidemiology of gastroesophageal reflux disease in Asia: A systematic review. J NeurogastroenterolMotil. 2011; 17:14-27.

Jafri N, Jafri W, Yakoob J, Islam M, Manzoor S, Jalil A, Hashmi F. Perception of gastroesophageal reflux disease in urban population in Pakistan. J Coll Physicians Surg Pak. 2005 Sep;15(9):532-4. PMID: 16181570.

Atta MM, Sayed MH, Zayed MA, Alsulami SA, Al-Maghrabi AT, Kelantan AY. Gastro-oesophageal reflux disease symptoms and associated risk factors among medical students, Saudi Arabia. Int J Gen Med. 2019 Aug 19; 12:293-298. doi: 10.2147/IJGM.S206995. PMID: 31692498; PMCID: PMC6707933.

Alhuzaim WM, Alotaibi AT, Alruwaybiah HA, Alharthi NS, Alzahrani SA, AlDera NM, AlKhudhair MR, Alassaf MF (2021). The prevalence and risk factors of GERD in the Kingdom of Saudi Arabia and the impact of Covid-19 pandemic. Int. Res. J. Pub. Environ. Health 8(5):284-292.

Badillo R, Francis D. Diagnosis, and treatment of gastroesophageal reflux disease. World J GastrointestPharmacolTher. 2014 Aug 6;5(3):105-12. doi: 10.4292/wjgpt. v5.i3.105. PMID: 25133039; PMCID: PMC4133436.

Zavala-Gonzales MA, Azamar-Jacome AA, Meixueiro-Daza A, Ramos A, J JR, Roesch-Dietlen F, Remes-Troche JM. Validation, and diagnostic usefulness of gastroesophageal reflux disease questionnaire in a primary care level in Mexico. J Neurogastroenterol Motil. 2014 Oct 30;20(4):475-82. doi: 10.5056/jnm14014. PMID: 25273118; PMCID: PMC4204416.

Jonasson C, Wernersson B, Hoff DA, Hatlebakk JG. Validation of the GerdQ questionnaire for the diagnosis of gastro-oesophageal reflux disease. Aliment PharmacolTher. 2013 Mar;37(5):564-72. doi: 10.1111/apt.12204. Epub 2013 Jan 7. PMID: 23289763.

Jones R, Junghard O, Dent J, Vakil N, Halling K, Wernersson B, Lind T. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Aliment PharmacolTher. 2009 Nov 15;30(10):1030-8. doi: 10.1111/j.1365-2036.2009.04142.x.Epub 2009 Sep 8. PMID: 19737151.

Mansour-Ghanaei F, Joukar F, Atshani SM, Chagharvand S, Souti F. The epidemiology of gastroesophageal reflux disease: a survey on the prevalence and the associated factors in a random sample of the general population in the Northern part of Iran. Int J Mol Epidemiol Genet. 2013 Sep 12;4(3):175-82. PMID: 24046810; PMCID: PMC3773569.

Familoni, O. B. (2008). An overview of stress in medical practice. In African health sciences (Vol. 8, Issue 1, pp. 6–7).

Corp. I. IBM SPSS Statistics for Windows. Armonk, NY; 2019

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007 Oct;370(9596):1453–7.

Sharma A, Sharma PK, Puri P. Prevalence, and the risk factors of gastro-esophageal reflux disease in medical students. Med J Armed Forces India. 2018 Jul;74(3):250-254. doi: 10.1016/j.mjafi.2017.08.005. Epub 2017 Oct 7. PMID: 30093768; PMCID: PMC6081271.

Alrashed AA, Aljammaz KI, Pathan A, Mandili AA, Almatrafi SA, Almotire MH, Bahkali SM. Prevalence and risk factors of gastroesophageal reflux disease among Shaqra University students, Saudi Arabia. J Family Med Prim Care. 2019 Feb;8(2):462-467. doi: 10.4103/jfmpc.jfmpc_443_18. PMID: 30984655; PMCID: PMC6436310.

Leta Melaku, Andualem Mossie, Alemayehu Negash, "Stress among Medical Students and Its Association with Substance Use and Academic Performance", Journal of Biomedical Education, vol. 2015, Article ID 149509, 9 pages, 2015. https://doi.org/10.1155/2015/149509

Martinucci I, de Bortoli N, Giacchino M, Bodini G, Marabotto E, Marchi S, Savarino V, Savarino E. Esophageal motility abnormalities in gastroesophageal reflux disease. World J Gastrointest Pharmacol Ther. 2014 May 6;5(2):86-96. doi: 10.4292/wjgpt. v5.i2.86. PMID: 24868489; PMCID: PMC4023328.

Zschau NB, Andrews JM, Holloway RH, Schoeman MN, Lange K, Tam WC, Holtmann GJ. Gastroesophageal reflux disease after diagnostic endoscopy in the clinical setting. World J Gastroenterol. 2013 Apr 28;19(16):2514-20. doi: 10.3748/wjg. v19.i16.2514. PMID: 23674853; PMCID: PMC3646142.

Mungan Z, Pınarbaşı Şimşek B. Which drugs are risk factors for the development of gastroesophageal reflux disease? Turk J Gastroenterol. 2017 Dec;28(Suppl 1): S38-S43. doi: 10.5152/tjg.2017.11. PMID: 29199166.

Choi JM, Yang JI, Kang SJ, Han YM, Lee J, Lee C, Chung SJ, Yoon DH, Park B, Kim YS. Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results from a Large Cross-sectional Study. J Neurogastroenterol Motil. 2018 Oct 1;24(4):593-602. doi: 10.5056/jnm18069. PMID: 30347938; PMCID: PMC6175551.